ID   SM5-1
AC   CVCL_UW40
DR   ATCC; HB-12588
DR   Wikidata; Q98132690
RX   Patent=US7666609;
RX   PubMed=11214818;
RX   PubMed=16405722;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12588.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P02751; Human FN1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 5
//
RX   Patent=US7666609;
RA   Guo Y.-J., Ma J.;
RT   "Method and composition for diagnosis of melanocytic lesions.";
RL   Patent number US7666609, 23-Feb-2010.
//
RX   PubMed=11214818; DOI=10.1007/s004030000186;
RA   Trefzer U., Rietz N., Chen Y.-W., Audring H., Herberth G., Siegel P.,
RA   Reinke S., Koniger P., Wu S.-G., Ma J., Liu Y.-J., Wang H., Sterry W.,
RA   Guo Y.-J.;
RT   "SM5-1: a new monoclonal antibody which is highly sensitive and
RT   specific for melanocytic lesions.";
RL   Arch. Dermatol. Res. 292:583-589(2000).
//
RX   PubMed=16405722; DOI=10.1186/1471-2407-6-8;
RA   Trefzer U., Chen Y.-W., Herberth G., Hofmann M.A., Kiecker F.,
RA   Guo Y.-J., Sterry W.;
RT   "The monoclonal antibody SM5-1 recognizes a fibronectin variant which
RT   is widely expressed in melanoma.";
RL   BMC Cancer 6:8.1-8.12(2006).
//